Patents Assigned to CELLSAFE CO., LTD.
  • Patent number: 8871749
    Abstract: Provided is a bone-transplant or bone-filling composition, which comprises a dihydroxybenzoic acid derivative which has been newly demonstrated to increase the activity of osteoblasts and so induce bone formation.
    Type: Grant
    Filed: April 25, 2011
    Date of Patent: October 28, 2014
    Assignee: Cellsafe Co., Ltd.
    Inventor: Jae-Jin Han
  • Patent number: 8815565
    Abstract: Provided is a method for culturing cells, which prevents the possibility of mycoplasma contamination by culturing the cells using biomass extract obtained by culturing a strain with amphidinol productivity, preferably a strain such as Amphidinium klebsii, Amphididinium carterae, and the like belonging to Dinoflagellates, or using a fraction obtained from the extract; and a method for removing mycoplasma contamination of the cells by culturing the cells contaminated by mycoplasma using the amphidinol derivatives. In addition, provided is a method for removing mycoplasma contamination of the cells, including a combination of single cell-isolating enzyme solution treatment and cell aggregate removal.
    Type: Grant
    Filed: November 24, 2010
    Date of Patent: August 26, 2014
    Assignee: Cellsafe Co., Ltd.
    Inventor: Jae-Jin Han
  • Patent number: 8809034
    Abstract: Provided is a method for culturing cells, which prevents the possibility of mycoplasma contamination by culturing the cells using biomass extract obtained by culturing a strain with amphidinol productivity, preferably a strain such as Amphidinium klebsii, Amphididinium carterae, and the like belonging to Dinoflagellates, or using a fraction obtained from the extract; and a method for removing mycoplasma contamination of the cells by culturing the cells contaminated by mycoplasma using the amphidinol derivatives. In addition, provided is a method for removing mycoplasma contamination of the cells, including a combination of single cell-isolating enzyme solution treatment and cell aggregate removal.
    Type: Grant
    Filed: November 26, 2013
    Date of Patent: August 19, 2014
    Assignee: Cellsafe Co., Ltd.
    Inventor: Jae-Jin Han
  • Publication number: 20140093955
    Abstract: Provided is a method for culturing cells, which prevents the possibility of mycoplasma contamination by culturing the cells using biomass extract obtained by culturing a strain with amphidinol productivity, preferably a strain such as Amphidinium klebsii, Amphididinium carterae, and the like belonging to Dinoflagellates, or using a fraction obtained from the extract; and a method for removing mycoplasma contamination of the cells by culturing the cells contaminated by mycoplasma using the amphidinol derivatives. In addition, provided is a method for removing mycoplasma contamination of the cells, including a combination of single cell-isolating enzyme solution treatment and cell aggregate removal.
    Type: Application
    Filed: November 26, 2013
    Publication date: April 3, 2014
    Applicant: CELLSAFE CO., LTD.
    Inventor: Jae-Jin HAN
  • Publication number: 20120244614
    Abstract: Provided is a method for culturing cells, which prevents the possibility of mycoplasma contamination by culturing the cells using biomass extract obtained by culturing a strain with amphidinol productivity, preferably a strain such as Amphidinium klebsii, Amphididinium carterae, and the like belonging to Dinoflagellates, or using a fraction obtained from the extract; and a method for removing mycoplasma contamination of the cells by culturing the cells contaminated by mycoplasma using the amphidinol derivatives. In addition, provided is a method for removing mycoplasma contamination of the cells, including a combination of single cell-isolating enzyme solution treatment and cell aggregate removal.
    Type: Application
    Filed: December 8, 2010
    Publication date: September 27, 2012
    Applicant: CELLSAFE CO., LTD.
    Inventor: Jae-Jin Han